Dietary supplements, herbs and oral anticoagulants: The nature of the evidence

Journal of Thrombosis and Thrombolysis

Volumn 25, Issue 1, 2008, Pages 72-77

  Wittkowsky, Ann K ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Anticoagulants; Dietary supplements; Drug interactions; Herbal products; Warfarin

Indexed keywords

AMINO ACID; ANTICOAGULANT AGENT; CHONDROITIN; CRANBERRY EXTRACT; CYCLOSPORIN; FISH OIL; FLURBIPROFEN; GLUCOSAMINE; GREEN TEA EXTRACT; HERBACEOUS AGENT; MINERAL; PLACEBO; UBIDECARENONE; VITAMIN; WARFARIN;

CLINICAL TRIAL; CONFERENCE PAPER; CRANBERRY JUICE; DIET SUPPLEMENTATION; DRUG CLEARANCE; EVIDENCE BASED PRACTICE; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HERBAL MEDICINE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; UNITED STATES;

ANTICOAGULANTS; DIETARY SUPPLEMENTS; FOOD-DRUG INTERACTIONS; HERB-DRUG INTERACTIONS; HUMANS; PLANT PREPARATIONS; REGISTRIES;

EID: 38049169039     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0110-0     Document Type: Conference Paper

References (35)

1. Eisenberg DM, Davis RB, Ettner SL et al (1998) Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 280:1569-1575
2. Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complimentary and alternative medicine use among adults. United States, 2002. Adv Data 343:1-19
3. Gunther S, Patterson RE, Kristal AR et al (2004) Demographic and health-related correlates of herbal and specialty supplement use. J Am Diet Assoc 104:27-34
4. Wood MJ, Stewart RL, Merry H et al (2003) Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 145:806-812
5. Chagan L, Bernstein D, Cheng JW et al (2005) Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York City. BMC Complement Altern Med 5:4-13
6. Holbrook AM, Pereira JA, Labiris R et al (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095-1106
7. Nutescu EA, Shapiro NL, Ibrahim S, West P (2006) Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf 5:433-451
8. Wong RS, Cheng G, Chan TY (2003) Use of herbal medicinals by patients receiving warfarin. Drug Saf 26:585-588
9. Ramsay NA, Kenny MW, Davies G, Patel JP (2005) Complimentary and alternative medicine use among patients starting warfarin. Br J Haematol 130:777-780
10. Smith L, Ernst E, Ewings P et al (2004) Co-ingestion of herbal medicines and warfarin. Br J Gen Practice 54:439-441
11. Zuckerman IH, Steinberger EK, Ryder P, Haines S (2002) Herbal product use among anticoagulation clinic patients. Am J Health-Syst Pharm 59:379-380
12. Wittkowsky AK, Bussey HI, Walker MB, Frei CR (2007) Dietary supplement use among anticoagulation clinic patients. J Thromb Haemost 5:875-877
13. Noonan C, Noonan WP (2006) Marketing dietary supplements in the United States: A review of the requirements for new dietary ingredients. Toxicology 221:4-8
14. Srinivasan VS (2006) Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopeia's dietary supplement verification program - a public health program. Life Sci 78:2039-2043
15. Huang SM, Temple R, Throckmorton DC, Lesko LJ (2007) Drug interaction studies: Study design, data analysis and implications for dosing and labeling. Nature 81:298-304
16. Aronson JK (2005) Unity from diversity: The evidential use of anecdotal reports of adverse drug reactions and interactions. J Eval Clin Pract 11:195-208
17. Kelly WN (2003) The quality of published adverse drug event reports. Ann Pharmcotherapy 37:1774-1778
18. Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245
19. Horn JR, Hansten PD, Chan LN (2007) Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacotherapy 41:674-680
20. Suvarna R, Pimrohamed M, Henderson L (2003) Possible interaction between warfarin and cranberry juice. BMJ 327:1454
21. Walsh KM (2005) Getting to yes. J Am Geriatr Soc 53:1072
22. Grant P (2004) Warfarin and cranberry juice. An interaction? J Heart Valv Dis 13:25-26
23. Rindone JP, Murphy TW (2006) Warfarin-cranberry juice interaction resulting in profound hypoprothrombininemia and bleeding. Am J Ther 13:283-284
24. Aston JL, Lodolce AE, Shapiro NL (2006) Interaction between warfarin and cranberry juice. Pharmacotherapy 26:1314-1319
25. Hodek P, Trefil P, Stiborova M (2002) Flavenoids: Potent and versatile biologically active compounds interacting with cytochrome P450. Chem Biol Interact 139:1-21
26. Committee on Safety of Medicines, Medicines and Healthcare Products Regulatory Agency (2004) Interaction between warfarin and cranberry juice: New advice. Current Problems in Pharmacovigilance 30:10
27. Greenblatt DJ, von Moltke LL, Perloff ES et al (2006) Interaction of flurbiprofen with cranberry juice, grape juice, tea and fluconazole. In vitro and clinical studies Clin Pharmacol Ther 79:125-133
28. Grenier J, Fradette C, Morelli G et al (2006) Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 79:255-262
29. Lilja JJ, Backman JT, Neuvonen PJ (2007) Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine and midazolam probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther; in press
30. Zhaoping LI, Seerman NP, Carpenter CL et al (2006) Cranberry does not affect prothrombin time in male subjects on warfarin. J Am Diet Assoc 106:2057-2061
31. Foti RS, Wahlstrom JL, Wienkers LC (2007) The in vitro drug interaction potential of dietary supplements containing multiple herbal components. Drug Metab Disp 35:185-188
32. Zhu YP, Woerdenbag HJ (1995) Traditional Chinese herbal medicine. Pharm World Sci 17:103-112
33. Tai MW, Sweet BV (2006) Nattokinase for prevention of thrombosis. Am J Health Syst Pharm 63:1121-1123
34. Cesarone MR, Belcaro G, Nicolaides AN et al (2003) Prevention of venous thrombosis in long-haul flights with Flite Tabs: The LONFLIT-FLITE randomized controlled trial. Angiology 54:531-539
35. Bussey HI, Tapson V, Cannon RO 3rd, Nolan PE Jr et al (2005) NIH conference on dietary supplements, session V: Opinions and research priorities. Thromb Res 117:155-169